MURA, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 835
EU - Europa 670
AS - Asia 471
OC - Oceania 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.984
Nazione #
US - Stati Uniti d'America 827
CN - Cina 446
IE - Irlanda 186
UA - Ucraina 143
FI - Finlandia 102
DE - Germania 95
SE - Svezia 43
IT - Italia 36
GB - Regno Unito 23
FR - Francia 20
SG - Singapore 19
BE - Belgio 11
CA - Canada 8
CZ - Repubblica Ceca 4
NL - Olanda 4
AU - Australia 3
RU - Federazione Russa 3
EU - Europa 2
IN - India 2
MU - Mauritius 2
JP - Giappone 1
MY - Malesia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 1.984
Città #
Chandler 191
Dublin 186
Jacksonville 163
Nanjing 136
Ann Arbor 55
Ashburn 55
Beijing 53
Boardman 50
Nanchang 47
Helsinki 38
Changsha 34
Hebei 34
Princeton 33
Shenyang 33
Lawrence 32
Jiaxing 29
Wilmington 29
Hangzhou 19
Medford 18
Shanghai 17
Tianjin 14
Pavia 12
Woodbridge 12
Brussels 11
Milan 11
Singapore 11
Norwalk 10
Los Angeles 9
Munich 9
Toronto 8
Kunming 6
Neckargemünd 6
Fairfield 5
Verona 5
Brno 4
New York 4
Washington 4
Phoenix 3
Taizhou 3
Zhengzhou 3
Falls Church 2
Houston 2
Philadelphia 2
Shirley 2
Vercelli 2
Adelaide 1
Amsterdam 1
Bangalore 1
Berlin 1
Bloomfield 1
Canberra 1
Changchun 1
Dongguan 1
Dunedin 1
Falkenstein 1
Guangzhou 1
Harbin 1
Hefei 1
Jinan 1
Lanzhou 1
Luoyang 1
Manchester 1
Mozzate 1
Ningbo 1
Nuremberg 1
Reston 1
Riyadh 1
Rockville 1
Santa Clara 1
Sydney 1
Taiyuan 1
Tappahannock 1
Tokyo 1
Totale 1.440
Nome #
1 Brain area-selective neuromodulatory action of beta-amyloid 93
Intrathecal baclofen in patients with persistent vegetative state: 2 hypotheses 87
La fibromialgia: basi biologiche e aspetti di farmacoterapia 84
Innovazione e terapia della malattia di Alzheimer: il punto di vista farmacologico 84
Effects of soluble β-amyloid on the release of neurotransmitters from rat brain synaptosomes. 83
Brain area-selective neuromodulatory action of beta-amyloid 81
Oxycodone pain management in cytochrome p450-impaired patients. 76
Appreciation of functional rather than lesional effects of beta amyloid (AB): a study on dopamine release following in vivo AB infusion 71
Different Effects of Beta-Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Aminoacids in Rat Hippocampus 66
Beta-amyloid: a disease target or a synaptic regulator affecting age-related neurotransmitter changes? 65
Awakenings and awareness recovery in disorders of consciousness is there a role for drugs? 64
Beta amyloid neuromodulatory activities: a challenge to beta amyloid targeting in Alzheimer's disease 64
Alternative views on beta amyloid: a disease target or a cell neuromodulator at the edge between signalling and degeneration. 63
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus 63
Neuromodulatory actions of beta-amyloid 1-40 on the muscarinic receptors modulating the release of ACh, GABA and DA from isolated nerve endings in the rat nucleus accumbens 62
Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus. 62
Inhibitory effects of beta-amyloid on the nicotinic receptors which stimulate glutamate release in rat hippocampus: the glial contribution 60
Specific neuromodulatory actions of beta-amyloid on dopamine release in rat nucleus accumbens and caudate putamen 59
Amyloid modulation of neurotransmission at synaptic level 58
Studio dei fattori di rischio genetico nella malattia di Alzheimer: il contributo del gene codificante il recettore α (ESR1) degli estrogeni. 56
β-amyloid modulates the function of nAChRs which stimulate, in vivo and in vitro, the release of glutamate, aspartate and GABA in rat hippocampus 54
Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens 54
Specific inhibitory effect of beta-amyloid on presynaptic muscarinic receptor subtypes modulating neurotranmitter release in the rat nucleus accumbens 53
Dual effect of beta-amyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus 52
Neuromodulatory actions of beta-amyloid on the DA release. 51
β-amyloid impairs the nicotinic-stimulated neurotransmitter release in rat hippocampus in absence of neurotoxicity 51
Stimulus-selective neuromodulatory action of beta-amyloid 49
Selective neuromodulatory action of beta-amyloid in different brain areas 49
Effect of beta-amyloid in vivo infusion on dopamine release in absence of lesional effects 46
β-amyloid influences nicotinic-stimulated release of both excitatory and inhibitory neurotransmitters in rat hippocampus 43
null 39
Pharmacological modulation of the state of awareness in patients with disorders of consciousness: an overview 36
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus. 24
Totale 2.002
Categoria #
all - tutte 7.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020158 0 0 0 0 0 33 8 30 2 55 29 1
2020/2021258 34 25 7 29 3 41 3 38 5 34 34 5
2021/2022153 3 3 6 3 6 14 7 13 8 2 22 66
2022/2023527 62 40 4 36 58 61 0 30 212 1 14 9
2023/2024183 34 32 9 13 25 32 6 4 2 15 8 3
2024/202580 16 42 12 10 0 0 0 0 0 0 0 0
Totale 2.002